Clinical practice guidelines for the management of atopic dermatitis 2018
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion. The current strategies to treat AD in Japan from the perspective of evidence‐based medicine consist of three primary measures: (i) the use of topical corticosteroids and tacrolimus ointment as the main treatment for the inflammation; (ii) topical application of emollients to treat the cutaneous barrier dysfunction; and (iii) avoidance of apparent exacerbating factors, psychological counseling and advice about daily life. The guidelines present recommendations to review clinical research articles, evaluate the balance between the advantages and disadvantages of medical activities, and optimize medical activity‐related patient outcomes with respect to several important points requiring decision‐making in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic features of atopic dermatitis
Hanifin, J. M., & Rajka, G. (1980) · Acta Dermato-Venereologica · doi:10.2340/00015555924447 · Cited by 5,086
Adherence to Long‐Term Therapies: Evidence for Action
Burkhart, P. V., & Sabaté, E. (2003) · Journal of Nursing Scholarship · doi:10.1111/j.1547-5069.2003.tb00001.x · Cited by 2,526
Kong, H. H., Oh, J., Deming, C., Conlan, S., Grice, E. A., Beatson, M. A., Nomicos, E., Polley, E. C., Komarow, H. D., Program, N. C. S., et al. (2012) · Genome Research · doi:10.1101/gr.131029.111 · Cited by 1,808
WILLIAMS, H. C., JBURNEY, P. G., HAY, R. J., ARCHER, C. B., SHIPLEY, M. J., AHUNTER, J. J., BINGHAM, E. A., FINLAY, A. Y., PEMBROKE, A. C., CGRAHAM-BROWN, R. A., et al. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08530.x · Cited by 1,271
The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis
Hanifin, J. M., Thurston, M., Omoto, M., Cherill, R., Tofte, S. J., Graeber, M., & Evaluator Group, T. E. (2001) · Experimental Dermatology · doi:10.1034/j.1600-0625.2001.100102.x · Cited by 1,200
WILLIAMS, H. C., JBURNEY, P. G., PEMBROKE, A. C., HAY, R. J., & Party, A. D. D. C. W. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08532.x · Cited by 926
Barrier Epithelial Cells and the Control of Type 2 Immunity
Hammad, H., & Lambrecht, B. N. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.007 · Cited by 847
Dermcidin: A novel human antibiotic peptide secreted by sweat glands
Schittek, B., Hipfel, R., Sauer, B., Bauer, J., Kalbacher, H., Stevanovic, S., Schirle, M., Schroeder, K., Blin, N., Meier, F., et al. (2001) · Nature Immunology · doi:10.1038/ni732 · Cited by 730
Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention
Simpson, E. L., Chalmers, J. R., Hanifin, J. M., Thomas, K. S., Cork, M. J., McLean, W. H. I., Brown, S. J., Chen, Z., Chen, Y., & Williams, H. C. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.005 · Cited by 722
Biology of sweat glands and their disorders. I. Normal sweat gland function
Sato, K., Kang, W. H., Saga, K., & Sato, K. T. (1989) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(89)70063-3 · Cited by 717
Epidemiologic risks for food allergy
Lack, G. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.04.032 · Cited by 700
Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
Ruzicka, T., Hanifin, J. M., Furue, M., Pulka, G., Mlynarczyk, I., Wollenberg, A., Galus, R., Etoh, T., Mihara, R., Yoshida, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606490 · Cited by 592
Zeiger, R. S., & Heller, S. (1995) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(95)70074-9 · Cited by 539
Fiocchi, A., Pawankar, R., Cuello-Garcia, C., Ahn, K., Al-Hammadi, S., Agarwal, A., Beyer, K., Burks, W., Canonica, G. W., Ebisawa, M., et al. (2015) · World Allergy Organization Journal · doi:10.1186/s40413-015-0055-2 · Cited by 473
Does atopic dermatitis cause food allergy? A systematic review
Tsakok, T., Marrs, T., Mohsin, M., Baron, S., du Toit, G., Till, S., & Flohr, C. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.049 · Cited by 368
Epidemiology of atopic dermatitis
Larsen, F. S., & Hanifin, J. M. (2002) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(03)00066-3 · Cited by 310
Schmitt, J., von Kobyletzki, L., Svensson, Å., & Apfelbacher, C. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10030.x · Cited by 257
Stalder, J.-F., Barbarot, S., Wollenberg, A., Holm, E. A., De Raeve, L., Seidenari, S., Oranje, A., Deleuran, M., Cambazard, F., Svensson, A., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02577.x · Cited by 255
Safety of dermatologic medications in pregnancy and lactation
Murase, J. E., Heller, M. M., & Butler, D. C. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.09.010 · Cited by 220
Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber
Werfel, T., Heratizadeh, A., Niebuhr, M., Kapp, A., Roesner, L. M., Karch, A., Erpenbeck, V. J., Lösche, C., Jung, T., Krug, N., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.04.015 · Cited by 171
Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study
PINCELLI, C., FANTINI, F., MASSIMI, P., GIROLOMONI, G., SEIDENARI, S., & GIANNETTI, A. (1990) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1990.tb06261.x · Cited by 153
Thymus and activation‐regulated chemokine as a clinical biomarker in atopic dermatitis
Kataoka, Y. (2014) · The Journal of Dermatology · doi:10.1111/1346-8138.12440 · Cited by 150
Exposure to Cats: Update on Risks for Sensitization and Allergic Diseases
Dharmage, S. C., Lodge, C. L., Matheson, M. C., Campbell, B., & Lowe, A. J. (2012) · Current Allergy and Asthma Reports · doi:10.1007/s11882-012-0288-x · Cited by 41
Cited by
Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus
Kabashima, K., Matsumura, T., Komazaki, H., & Kawashima, M. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1917006 · Cited by 361
Passeron, T., Lim, H. W., Goh, C. ‐., Kang, H. Y., Ly, F., Morita, A., Ocampo Candiani, J., Puig, S., Schalka, S., Wei, L., et al. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17242 · Cited by 221
Eight novel susceptibility loci and putative causal variants in atopic dermatitis
Tanaka, N., Koido, M., Suzuki, A., Otomo, N., Suetsugu, H., Kochi, Y., Tomizuka, K., Momozawa, Y., Kamatani, Y., Ikegawa, S., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.04.019 · Cited by 74
Jelousi, S., Sharma, D., Alexis, A., & Murase, J. E. (2022) · Dermatology and Therapy · doi:10.1007/s13555-022-00823-w · Cited by 13
“Although stress management and behavioral modifications have been shown to improve itching symptom of AD, displaced communities often have limited access to healthcare services, including mental health services, compounding their disease and perpetuating health disparities [73].”
Background
Metadata
- Authors
- Katoh, N., Ohya, Y., Ikeda, M., Ebihara, T., Katayama, I., Saeki, H., Shimojo, N., Tanaka, A., Nakahara, T., Nagao, M., Hide, M., Fujita, Y., Fujisawa, T., Futamura, M., Masuda, K., Murota, H., & Yamamoto‐Hanada, K.
- Venue
- The Journal of Dermatology
- Publisher
- Wiley
- Published
- 2019-10-09
- Volume
- 46
- Issue
- 12
- Pages
- 1053-1101
- ISSN
- 0385-2407 (ISSN-L)
- 1346-8138
- OpenAlex
- W2979813410
- Cited by
- 131
- References
- 23
- FWCI
- 16.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.